Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency

Shock

Volumn 31, Issue 6, 2009, Pages 553-560

  Matejec, Reginald ^a   Löcke, Gudrun ^b   Mühling, Jörg ^a   Harbach, Heinz Walter ^a   Langefeld, Tanja Wiebke ^a   Bödeker, Rolf Hasso ^a   Hempelmann, Gunter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

melanocyte stimulating hormone ( MSH); lipotropin ( LPH); Authentic endorphin endorphin (1 31) ; Corticotropin (ACTH); Corticotropin releasing hormone (CRH); Hypothalamic pituitaryadrenal (HPA) axis; N acetyl endorphin (Nac END)

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; LOW DENSITY LIPOPROTEIN; N ACETYL BETA ENDORPHIN; PROOPIOMELANOCORTIN; TETRACOSACTIDE;

ACTH SECRETING CELL; ADRENAL CORTEX INSUFFICIENCY; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS FUNCTION; IMMUNOREACTIVITY; MALE; MELANOTROPH; MORTALITY; PROVOCATION TEST; SEPTIC SHOCK; SURVIVOR;

ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; ALPHA-MSH; BETA-ENDORPHIN; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 68049113647     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318188dfb8     Document Type: Article

References (37)

1. Legakis I, Saramantis A, Voros D, Chalevelakis G, Tolis G: Dissociation of ACTH, b-endorphin and cortisol in graded sepsis. Horm Metab Res 30: 570-574, 1998.
2. Glembotski CC: Acetylation of alpha-MSH and beta-endorphin in the rat intermediate pituitary. Subcellular localization. J Biol Chem 257:10493-10500, 1982.
3. Castro MG, Morrison E: Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol 11:35-57, 1997.
4. Evans VR, Manning AB, Bernard LH, Chronwall BM, Millington WR: α-Melanocyte-stimulating hormone and N-acetyl-b-endorphin immunoreactivities are localized in the human pituitary but are not restricted to the zona intermedia. Endocrinology 134:97-106, 1994.
5. Annane D, Sébille V, Charpentier C, Bollaert P-E, François B, Korach J-M, Capellier G, Cohen Y, Azoulay E, Troché G, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871, 2002.
6. Lipiner-Friedman D, Sprung CL, Laterre PF, Weis Y, Goodman SV, Vogeser M, Briegel J, Keh D, Singer M, Moreno R, et al.: Adrenal function in sepsis: the retrospective cortices cohort study. Crit Care Med 35:1012-1018, 2007.
7. Akil D, Shiomi H, Matthews J: Induction of the intermediate pituitary by stress: synthesis and release of a nonopioid form of beta-endorphin. Science 227:424-426, 1985.
8. Lindley SE, Lookingland KJ, Moore KE: Dopaminergic and beta-adrenergic receptor control of alpha-melanocyte-stimulating hormone secretion during stress. Neuroendocrinology 52:46-51, 1990.
9. Lookingland KJ, Gunnet JW, Moore KE: Stress-induced secretion of alpha-melanocyte-stimulating hormone is accompanied by the decrease in the activity of tuberohypophysial dopaminergic neurons. Neuroendocrinology 53: 91-96, 1991.
10. Kjaer A, Knigge U, Bach FW, Warberg J: Stress-induced secretion of proopiomelanocortin-derived peptides in rats: relative importance of the anterior and intermediate pituitary lobes. Neuroendocrinology 61:167-172, 1995.
11. Catania A, Delgado R, Airaghi L, Cutuli M, Garofalo L, Carlin A, Demitri MT, Lipton JM: Alpha-MSH in systemic inflammation: central and peripheral actions. Ann N Y Acad Sci 885:183-187, 1999.
12. Grieco P, Rossi C, Colombo G, Gatti S, Novellino E, Lipton JM, Catania A: Novel alpha-melanocyte stimulating hormone peptide analogues with high candidacidal activity. J Med Chem 46:850-855, 2003.
13. Rothwell PM, Udwadia ZF, Lawler PG: Cortisol response to corticotropin and survival in septic shock. Lancet 337:582-583, 1991.
14. Annane D, Sébille V, Troché G, Raphael JC, Gajdos P, Bellissant E: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283:1038-1045, 2000.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
16. Wiedemann K, Teschemacher H: Determination of b-endorphin and fragments thereof in human plasma using high-performance liquid chromatography and a multiple radioimmunoassay system. Pharmacol Res Commun 3:142-149, 1986.
17. Harbach HW, Hell K, Gramsch C, Katz N, Hempelmann G, Teschemacher H: b-endorphin (1-31) in the plasma of male volunteers undergoing physical exercise. Psychoneuroendocrinology 25:551-562, 2000.
18. Hunter WM, Greenwood FC: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496, 1962.
19. Schulz A, Harbach H, Katz N, Geiger L, Teschemacher H: β-Endorphin immunoreactive material and authentic b-endorphin in the plasma of males undergoing anaerobic exercise on a rowing ergometer. Int J Sports Med 21: 513-517, 2000.
20. Matejec R, Schulz A, Harbach HW, Uhlich H, Hempelmann G, Teschemacher H: Effects of tourniquet-induced ischemia on the release of proopiomelanocortin derivatives determined in peripheral blood plasma. J Appl Physiol 97:1040-1045, 2004.
21. Matejec R, Uhlich H, Hotz C, Mühling J, Harbach HW, Bödeker R-H, Hempelmann G, Teschemacher H: Corticotropin-releasing hormone reduces pressure pain sensitivity in humans without involvement of β-endorphin(1- 31), but does not reduce heat pain sensitivity. Neuroendocrinology 82:185-197, 2005.
22. Matejec R, Harbach HW, Bödeker R-H, Hempelmann G, Teschemacher H: Plasma levels of corticotroph-type POMC derivatives such as b-lipotropin, β-endorphin(1-31) or ACTH are correlated with severity of postoperative pain. Clin J Pain 22:113-121, 2006.
23. Matejec R, Schulz A, Mühling J, Uhlich H, Bödeker R-H, Hempelmann G, Teschemacher H: Preoperative concentration of beta-lipotropin immunoreactive material in cerebrospinal fluid: a predictor of postoperative pain? Neuropeptides 40:11-21, 2006.
24. Matejec R, Ruwoldt R, Bödeker RH, Hempelmann G, Teschemacher H: Release of b-endorphin immunoreactive material under perioperative conditions into blood or cerebrospinal fluid: significance for postoperative pain? Anesth Analg 96:481-486, 2003.
25. Hollander M, Wolfe DA: Nonparametric Statistical Methods. 1st ed. New York, London, Sydney, Toronto: John Wiley and Sons Inc., pp. 33-64, 1973.
26. Fuchs PC, Groger A, Bozkurt A, Johnen D, Wolter T, Pullua N: Cortisol in severely burned patients: investigations on disturbance of the hypothalamus-pituitary-adrenal axis. Shock 28:662-667, 2007.
27. Imura H, Fukata J: Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic- pituitaryadrenal axis in inflammation. Eur J Endocrinol 130:32-37, 1994.
28. Briegel J, Schelling G, Haller M, Mraz W, Forst H, Peter K: A comparison of the adrenocortical response during septic shock and after complete recovery. Int Care Med 22:894-899, 1996.
29. Vermes I, Beishuizen A, Hampsink RM, Haan C: Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80: 1238-1242, 1995.
30. Bornstein SR, Chrousos GP: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 84:1729-1736, 1999.
31. Proulx-Ferland L, Labrie F, Dumont D, Côté J, Coy DH, Sveiraf J: Corticotropin-releasing factor stimulates secretion of melanocyte-stimulating hormone from the rat pituitary. Science 217:62-63, 1982.
32. Meunier H, Lefèvre G, Dumont D, Labrie F: CRF stimulates alpha-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells. Life Sci 31:2129-2135, 1982.
33. Lipton JM, Ceriani G, Macaluso A, McCoy D, Carnes K, Biltz J, Catania A: Antiinflammatory effects of the neuropeptide a-MSH in acute, chronic, and systemic inflammation. Ann N Y Acad Sci 741:137-148, 1994.
34. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM: Alpha-MSH in systemic inflammation: central and peripheral actions. Peptides 17:675-679, 1996.
35. Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, Gattinoni L: Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med 28:1403-1407, 2000.
36. Furutani M, Arii S, Higashitsuji H, Mise M, Fukumoto M, Takano S, Nakayama H, Imamura M, Fujita J: Reduced expression of kan-1 (encoding putative bile acid-CoA-amino acid N-acyltransferase) mRNA in livers of rats after partial hepatectomy and during sepsis. Biochem J 311:203-208, 1995.
37. Chen YH, Hong IC, Kuo KK, Hsu HK, Hsu C: Role of retinoid-X receptor-alpha in the suppression of rat bile acid coenzyme A-amino acid N-acyltransferase in liver during sepsis. Shock 28:65-70, 2007.